Accumulated evidence in recent years has shown that the variation of h
epatitis B virus (HBV) genomes may have profound implications for our
understanding of hepatitis B pathogenesis and prevention, Attention ha
s focused on areas of the outer envelope coded by the S gene which are
involved in the induction of a protective neutralising antibody respo
nse, and mutations which directly affect. the production of C gene pro
ducts, one of which is considered as a target for immune T cells invol
ved in virus clearance. This review highlights recent experimental dat
a which emphasizes the role of such mutations in the establishment and
maintenance of chronic HBV infections and focuses attention on the si
gnificance of HBV variants with respect to the expanding use of HBV va
ccines for mass immunization.